ArticleCancer chemotherapy and pharmacology2023

Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.

Anna Maria Militello et al.PubMed ↗Publisher ↗

No numbers read from the abstract.